Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy

@inproceedings{Haghikia2015RationaleAD,
  title={Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy},
  author={Arash Haghikia and Edith Katharina Podewski and Dominik Berliner and Kristina Sonnenschein and Dieter Fischer and Christiane E. Angermann and Michael B{\"o}hm and Philipp Roentgen and Johann Bauersachs and Denise Hilfiker-Kleiner},
  booktitle={Clinical Research in Cardiology},
  year={2015}
}
Peripartum cardiomyopathy (PPCM) is an idiopathic heart disease that develops in the last month of pregnancy and/or the first months following delivery in previously healthy women and may lead to acute heart failure. A cleaved fragment of the nursing hormone prolactin is considered essential in the pathophysiology of PPCM. To date, no specific therapy has been tested for PPCM in a randomized controlled trial of adequate size. The purpose of this trial is to investigate the safety of the dopamin… CONTINUE READING